Back
Context Therapeutics Stock Price Chart
Sponsored
CNTX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
66
CNTX
Context Therapeutics
Last Price:
2.37
Seasonality Move:
-29.9%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Context Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.1 | Buy |
20-day SMA: | 2.29 | Sell |
50-day SMA: | 2.3 | Sell |
200-day SMA: | 1.62 | Buy |
8-day EMA: | 2.13 | Buy |
20-day EMA: | 2.23 | Sell |
50-day EMA: | 2.23 | Sell |
200-day EMA: | 1.78 | Buy |
Context Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 48.11 | Sell |
Chaikin Money Flow: | 35314 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.14 - 2.54) | Sell |
Bollinger Bands (100): | (1.81 - 2.37) | Buy |
Context Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Context Therapeutics Stock
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 2.22 while CNTX 8-day simple moving average is 2.10, which is a Buy signal.
- The stock price of CNTX is 2.22 while Context Therapeutics 20-day SMA is 2.29, which makes it a Sell.
- Context Therapeutics 50-day simple moving average is 2.30 while CNTX share price is 2.22, making it a Sell technically.
- CNTX stock price is 2.22 and Context Therapeutics 200-day simple moving average is 1.62, creating a Buy signal.
CNTX Technical Analysis vs Fundamental Analysis
Buy
66
Context Therapeutics (CNTX)
is a Buy
Is Context Therapeutics a Buy or a Sell?
-
Context Therapeutics stock is rated a Buy
The current Context Therapeutics [CNTX] share price is $2.22. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Context Therapeutics Stock Info
Market Cap:
166.5M
Price in USD:
2.22
Share Volume:
38.14K
Context Therapeutics 52-Week Range
52-Week High:
2.75
52-Week Low:
0.77
Buy
66
Context Therapeutics (CNTX)
is a Buy
Context Therapeutics Share Price Forecast
-
What is the Context Therapeutics stock price today?
The Context Therapeutics stock price is 2.22 USD today. -
Will CNTX stock go up or go down?
Context Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Context Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Context Therapeutics is not overvalued.
Is Context Therapeutics Stock a Buy?
- Context Therapeutics share price is 2.22 while CNTX 8-day exponential moving average is 2.13, which is a Buy signal.
- The stock price of CNTX is 2.22 while Context Therapeutics 20-day EMA is 2.23, which makes it a Sell.
- Context Therapeutics 50-day exponential moving average is 2.23 while CNTX share price is 2.22, making it a Sell technically.
- CNTX stock price is 2.22 and Context Therapeutics 200-day simple moving average is 1.78, creating a Buy signal.
Fundamental Analysis of Context Therapeutics
Is Context Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Context Therapeutics
Should I short Context Therapeutics stock?
- CNTX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Context Therapeutics is a Sell
- Context Therapeutics Relative Strength Index (RSI) is 48.11, which suggest Context Therapeutics is oversold
- The Bollinger Bands (25) for Context Therapeutics is (2.14 - 2.54), which suggest Context Therapeutics is a Buy
- The Bollinger Bands (100) for Context Therapeutics is (1.81 - 2.37), which suggest Context Therapeutics is a Buy
* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.